Mergers & Acquisitions ·
On June 9, 2026, Nasdaq granted Wellgistics Health, Inc. an extension until October 12, 2026, to regain compliance…
WGRXWellgistics Health, Inc.
On June 9, 2026, Nasdaq granted Wellgistics Health, Inc. an extension until October 12, 2026, to regain compliance with Listing Rule 5550(b)(1) regarding the Minimum Stockholders' Equity Requirement of $2.5 million, as the company reported stockholders' equity of $(12,447,801) as of December 31, 2025. To remedy this, the company is pursuing a combination with DataVault AI to create DelivMeds AI and intends to acquire a patent portfolio and a controlling stake in Tollo Health, targeting post-transaction stockholders' equity of approximately $40 million. Separately, Nasdaq notified the company on June 9, 2026, that it has regained compliance with the Minimum Bid Price Requirement of $1.00 per share. The company operates in the healthcare sector, providing health-related logistics and technology services.